1 completed, 1 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Recruiting 1 |
Follow Mastocytosis: new trials by email Literature Review of Mastocytosis trials Research Report on Mastocytosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Avapritinib Rollover Study Avapritinib - Mastocytosis, Systemic | Phase 4 | Recruiting | Blueprint Medicines Corporation | 60 | 2024-11-28 | 2026-11-12 |
| Imatinib in KIT-negative Systemic Mastocytosis Imatinib Mesylate - Systemic Mastocytosis | Phase 4 | Completed | Hospital Virgen de la Salud | 10 | 2011-01-01 | 2016-08-29 |
Mastocytosis, Systemic (2) · Mast Cell Activation Disorders (1)
Immune System Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Connective Tissue (2) · Neoplasms, Connective and Soft Tissue (2) · Mast Cell Activation Disorders (1)
Imatinib Mesylate (1) · avapritinib (1)
Blueprint Medicines Corporation (1) · Hospital Virgen de la Salud (1)
Spain (2) · Belgium (1) · Canada (1) · France (1) · Germany (1) · Italy (1) · Netherlands (1) · Norway (1) · United Kingdom (1)